<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-7067887818437344832</id><updated>2012-02-29T04:42:04.609-08:00</updated><category term='Personalized Cosmetics'/><category term='New Zealand'/><category term='DermaNest'/><category term='international'/><category term='Convergent Technologies'/><category term='Montpellier'/><title type='text'>MedNest</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://mednest.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://mednest.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>MedNest</name><uri>http://www.blogger.com/profile/14190789665083370179</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='29' src='http://4.bp.blogspot.com/_vjdz7sQNGZs/TUVnN-atcYI/AAAAAAAAAyw/ZBkAnA6JEcg/s220/MedNEst%2BBlue%2BCross.JPG'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>5</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-7067887818437344832.post-7524220050499124484</id><published>2012-02-29T04:39:00.000-08:00</published><updated>2012-02-29T04:42:04.618-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Personalized Cosmetics'/><category scheme='http://www.blogger.com/atom/ns#' term='DermaNest'/><title type='text'>MedNest Incorporates and Launches DermaNest</title><content type='html'>&lt;p class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; text-align: justify; "&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Tahoma&amp;quot;,&amp;quot;sans-serif&amp;quot;;mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-US"&gt;PRINCETON, NJ , February 27 2012; &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: Tahoma, sans-serif; "&gt;MedNest incorporates and launches DermaNest as a wholly owned subsidiary. The mission of DermaNest is to commercialize &lt;/span&gt;&lt;span style="font-size: 9pt; font-family: Verdana, sans-serif; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: white; "&gt;develops the business of International &lt;strong&gt;Personalized Cosmetics and Skin-Care Solutions&lt;/strong&gt;&lt;span class="apple-converted-space"&gt; &lt;/span&gt;and &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: Tahoma, sans-serif; "&gt;Services for the US Markets.&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; text-align: justify; "&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Tahoma&amp;quot;,&amp;quot;sans-serif&amp;quot;;mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-US"&gt;“There is a growing number of non-destructive and portable skin and wound imaging and diagnostic technologies that can enable a personalized approach to dermatology therapeutic programs and cosmetic products. Such solutions will enhance would and skin disease treatments and will take into accounts all aspect of skin. All combined, DermaNest is poised to be the catalyst of a personal approach to skin science.” says Mathieu Petitjean, PhD, President of MedNest.&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; text-align: justify; "&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Tahoma&amp;quot;,&amp;quot;sans-serif&amp;quot;;mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-US"&gt;DermaNest already benefits from a remarkable track record of international clients and partners in this field developed by MedNest including SkinLabs, Agigma, Cytoo, LLTech, Une Fois un Jour among others. Such technologies have the potential to enhance the quality of the Research and Development of new therapies for skin diseases, or new actives compounds for the cosmetic market, in the same way personalized medicine is poised to revolutionize the approach and the business models related to healthcare. These technologies will focus not only on better characterizing various skin structures and variations but also look at the interactions of stimuli and compounds to the structure and how in turn the skin responds.  Applications will include deposition, retention and penetration of actives; sensitization, irritation and photo-damage; wound healing; skin barrier functionality; and the moisturization, appearance and overall health of skin&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; text-align: justify; "&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Tahoma&amp;quot;,&amp;quot;sans-serif&amp;quot;;mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-US"&gt;The DermaNest team offers a unique combination of highly experienced scientists and commercial leaders who will be focused on the development of relevant applications and value creation in the dermatology and cosmetic markets.&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; text-align: justify; "&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Tahoma&amp;quot;,&amp;quot;sans-serif&amp;quot;;mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-US"&gt;DermaNest's business model and highly experienced team empower early stage companies to play in high growth market segments, at a fraction of the cost of alternative solutions. Foreign companies who are interested to participate to the emerging growth of the personalized skin care and cosmetics in the US are invited to reach out to the DermaNest team (&lt;a href="http://www.dermanest.com/"&gt;www.dermanest.com&lt;/a&gt;)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; text-align: justify; "&gt;&lt;span lang="EN" style="font-size:10.0pt;font-family:&amp;quot;Tahoma&amp;quot;,&amp;quot;sans-serif&amp;quot;;mso-bidi-font-family: &amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7067887818437344832-7524220050499124484?l=mednest.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mednest.blogspot.com/feeds/7524220050499124484/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=7067887818437344832&amp;postID=7524220050499124484' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default/7524220050499124484'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default/7524220050499124484'/><link rel='alternate' type='text/html' href='http://mednest.blogspot.com/2012/02/mednest-incorporates-and-launches.html' title='MedNest Incorporates and Launches DermaNest'/><author><name>MedNest</name><uri>http://www.blogger.com/profile/14190789665083370179</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='29' src='http://4.bp.blogspot.com/_vjdz7sQNGZs/TUVnN-atcYI/AAAAAAAAAyw/ZBkAnA6JEcg/s220/MedNEst%2BBlue%2BCross.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7067887818437344832.post-8413944804203497051</id><published>2011-04-06T07:49:00.000-07:00</published><updated>2011-04-06T07:53:04.480-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Montpellier'/><title type='text'>Meeting the MedTech Ecosystem in Montpellier, France</title><content type='html'>In close collaboration with the International Team at the Agglomeration &lt;span id="SPELLING_ERROR_0" class="blsp-spelling-error"&gt;Montpellier&lt;/span&gt;, &lt;span id="SPELLING_ERROR_1" class="blsp-spelling-error"&gt;Mathieu&lt;/span&gt; &lt;span id="SPELLING_ERROR_2" class="blsp-spelling-error"&gt;Petitjean&lt;/span&gt;, CEO of &lt;span id="SPELLING_ERROR_3" class="blsp-spelling-error"&gt;MedNest&lt;/span&gt; will give a conference in front of a select group of &lt;span id="SPELLING_ERROR_4" class="blsp-spelling-error"&gt;MedTech&lt;/span&gt; entrepreneurs. The theme of the conference is " &lt;span id="SPELLING_ERROR_5" class="blsp-spelling-error"&gt;MedTech&lt;/span&gt; Markets in the USA: Opportunities for Entrepreneurs". The conference will be followed by a Q&amp;amp;A session. If you plan to join the conference, please post your questions in advance... that will help the speaker to come prepared ! Looking forward to a rich interaction. &lt;span id="SPELLING_ERROR_6" class="blsp-spelling-error"&gt;Mathieu&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7067887818437344832-8413944804203497051?l=mednest.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mednest.blogspot.com/feeds/8413944804203497051/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=7067887818437344832&amp;postID=8413944804203497051' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default/8413944804203497051'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default/8413944804203497051'/><link rel='alternate' type='text/html' href='http://mednest.blogspot.com/2011/04/meeting-medtech-ecosystem-in.html' title='Meeting the MedTech Ecosystem in Montpellier, France'/><author><name>MedNest</name><uri>http://www.blogger.com/profile/14190789665083370179</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='29' src='http://4.bp.blogspot.com/_vjdz7sQNGZs/TUVnN-atcYI/AAAAAAAAAyw/ZBkAnA6JEcg/s220/MedNEst%2BBlue%2BCross.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7067887818437344832.post-6869541598295304952</id><published>2011-01-30T06:51:00.000-08:00</published><updated>2011-01-30T06:58:00.526-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Convergent Technologies'/><category scheme='http://www.blogger.com/atom/ns#' term='international'/><category scheme='http://www.blogger.com/atom/ns#' term='New Zealand'/><title type='text'>New Zealand: a Global Ambition: Convergence of Medical Technologies and Health IT</title><content type='html'>&lt;span id="SPELLING_ERROR_0" class="blsp-spelling-error"&gt;This&lt;/span&gt; &lt;span id="SPELLING_ERROR_1" class="blsp-spelling-error"&gt;event&lt;/span&gt; will &lt;span id="SPELLING_ERROR_2" class="blsp-spelling-error"&gt;showcase&lt;/span&gt; &lt;span id="SPELLING_ERROR_3" class="blsp-spelling-error"&gt;both&lt;/span&gt; &lt;span id="SPELLING_ERROR_4" class="blsp-spelling-error"&gt;the&lt;/span&gt; &lt;span id="SPELLING_ERROR_5" class="blsp-spelling-error"&gt;New&lt;/span&gt; &lt;span id="SPELLING_ERROR_6" class="blsp-spelling-error"&gt;Zealand&lt;/span&gt; &lt;span id="SPELLING_ERROR_7" class="blsp-spelling-error"&gt;Emerging&lt;/span&gt; &lt;span id="SPELLING_ERROR_8" class="blsp-spelling-error"&gt;Medical&lt;/span&gt; &lt;span id="SPELLING_ERROR_9" class="blsp-spelling-error"&gt;Technology&lt;/span&gt; &lt;span id="SPELLING_ERROR_10" class="blsp-spelling-error"&gt;sector&lt;/span&gt; &lt;span id="SPELLING_ERROR_11" class="blsp-spelling-error"&gt;and&lt;/span&gt; &lt;span id="SPELLING_ERROR_12" class="blsp-spelling-error"&gt;the&lt;/span&gt; &lt;span id="SPELLING_ERROR_13" class="blsp-spelling-error"&gt;Health&lt;/span&gt; IT &lt;span id="SPELLING_ERROR_14" class="blsp-spelling-error"&gt;Sector&lt;/span&gt; &lt;span id="SPELLING_ERROR_15" class="blsp-spelling-error"&gt;and&lt;/span&gt; &lt;span id="SPELLING_ERROR_16" class="blsp-spelling-error"&gt;connect&lt;/span&gt; &lt;span id="SPELLING_ERROR_17" class="blsp-spelling-error"&gt;with&lt;/span&gt; &lt;span id="SPELLING_ERROR_18" class="blsp-spelling-error"&gt;them&lt;/span&gt; &lt;span id="SPELLING_ERROR_19" class="blsp-spelling-error"&gt;with&lt;/span&gt; &lt;span id="SPELLING_ERROR_20" class="blsp-spelling-error"&gt;both&lt;/span&gt; &lt;span id="SPELLING_ERROR_21" class="blsp-spelling-error"&gt;local&lt;/span&gt; &lt;span id="SPELLING_ERROR_22" class="blsp-spelling-error"&gt;and&lt;/span&gt; international &lt;span id="SPELLING_ERROR_23" class="blsp-spelling-error"&gt;resources&lt;/span&gt; &lt;span id="SPELLING_ERROR_24" class="blsp-spelling-error"&gt;of&lt;/span&gt; &lt;span id="SPELLING_ERROR_25" class="blsp-spelling-error"&gt;knowledge&lt;/span&gt; &lt;span id="SPELLING_ERROR_26" class="blsp-spelling-error"&gt;and&lt;/span&gt; &lt;span id="SPELLING_ERROR_27" class="blsp-spelling-error"&gt;expertise&lt;/span&gt;.&lt;br /&gt;&lt;br /&gt;&lt;span id="SPELLING_ERROR_28" class="blsp-spelling-error"&gt;Hon&lt;/span&gt; &lt;span id="SPELLING_ERROR_29" class="blsp-spelling-error"&gt;Gerry&lt;/span&gt; &lt;span id="SPELLING_ERROR_30" class="blsp-spelling-error"&gt;Brownlee&lt;/span&gt; will &lt;span id="SPELLING_ERROR_31" class="blsp-spelling-error"&gt;speak&lt;/span&gt; &lt;span id="SPELLING_ERROR_32" class="blsp-spelling-error"&gt;to&lt;/span&gt; &lt;span id="SPELLING_ERROR_33" class="blsp-spelling-error"&gt;the&lt;/span&gt; &lt;span id="SPELLING_ERROR_34" class="blsp-spelling-error"&gt;delegates&lt;/span&gt; &lt;span id="SPELLING_ERROR_35" class="blsp-spelling-error"&gt;on&lt;/span&gt; &lt;span id="SPELLING_ERROR_36" class="blsp-spelling-error"&gt;latest&lt;/span&gt; &lt;span id="SPELLING_ERROR_37" class="blsp-spelling-error"&gt;goverment&lt;/span&gt; &lt;span id="SPELLING_ERROR_38" class="blsp-spelling-error"&gt;initiatives&lt;/span&gt; &lt;span id="SPELLING_ERROR_39" class="blsp-spelling-error"&gt;to&lt;/span&gt; &lt;span id="SPELLING_ERROR_40" class="blsp-spelling-error"&gt;help&lt;/span&gt; &lt;span id="SPELLING_ERROR_41" class="blsp-spelling-error"&gt;support&lt;/span&gt; &lt;span id="SPELLING_ERROR_42" class="blsp-spelling-error"&gt;this&lt;/span&gt; &lt;span id="SPELLING_ERROR_43" class="blsp-spelling-error"&gt;growing&lt;/span&gt; &lt;span id="SPELLING_ERROR_44" class="blsp-spelling-error"&gt;sector&lt;/span&gt;.&lt;br /&gt;&lt;br /&gt;&lt;span id="SPELLING_ERROR_45" class="blsp-spelling-error"&gt;Please&lt;/span&gt; &lt;span id="SPELLING_ERROR_46" class="blsp-spelling-error"&gt;joint&lt;/span&gt; &lt;span id="SPELLING_ERROR_47" class="blsp-spelling-error"&gt;MedNest&lt;/span&gt; &lt;span id="SPELLING_ERROR_48" class="blsp-spelling-error"&gt;at&lt;/span&gt; &lt;span id="SPELLING_ERROR_49" class="blsp-spelling-error"&gt;the&lt;/span&gt; &lt;span id="SPELLING_ERROR_50" class="blsp-spelling-error"&gt;Langham&lt;/span&gt; Hotel, &lt;span id="SPELLING_ERROR_51" class="blsp-spelling-error"&gt;Auckland&lt;/span&gt;, &lt;span id="SPELLING_ERROR_52" class="blsp-spelling-error"&gt;on&lt;/span&gt; Feb 14&lt;span id="SPELLING_ERROR_53" class="blsp-spelling-error"&gt;th&lt;/span&gt; &lt;span id="SPELLING_ERROR_54" class="blsp-spelling-error"&gt;and&lt;/span&gt; Feb 15&lt;span id="SPELLING_ERROR_55" class="blsp-spelling-error"&gt;th&lt;/span&gt;.&lt;br /&gt;&lt;br /&gt;&lt;span id="SPELLING_ERROR_56" class="blsp-spelling-error"&gt;Mathieu&lt;/span&gt; &lt;span id="SPELLING_ERROR_57" class="blsp-spelling-error"&gt;Petitjean&lt;/span&gt; &lt;span id="SPELLING_ERROR_58" class="blsp-spelling-error"&gt;of&lt;/span&gt; &lt;span id="SPELLING_ERROR_59" class="blsp-spelling-error"&gt;MedNest&lt;/span&gt; will &lt;span id="SPELLING_ERROR_60" class="blsp-spelling-error"&gt;deliver&lt;/span&gt; a &lt;span id="SPELLING_ERROR_61" class="blsp-spelling-error"&gt;key&lt;/span&gt; &lt;span id="SPELLING_ERROR_62" class="blsp-spelling-error"&gt;note&lt;/span&gt; &lt;span id="SPELLING_ERROR_63" class="blsp-spelling-error"&gt;presentation&lt;/span&gt; &lt;span id="SPELLING_ERROR_64" class="blsp-spelling-error"&gt;on&lt;/span&gt; &lt;span id="SPELLING_ERROR_65" class="blsp-spelling-error"&gt;Medical&lt;/span&gt; &lt;span id="SPELLING_ERROR_66" class="blsp-spelling-error"&gt;Convergent&lt;/span&gt; &lt;span id="SPELLING_ERROR_67" class="blsp-spelling-error"&gt;Technology&lt;/span&gt; &lt;span id="SPELLING_ERROR_68" class="blsp-spelling-error"&gt;opportunities&lt;/span&gt; in &lt;span id="SPELLING_ERROR_69" class="blsp-spelling-error"&gt;the&lt;/span&gt; USA.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7067887818437344832-6869541598295304952?l=mednest.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mednest.blogspot.com/feeds/6869541598295304952/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=7067887818437344832&amp;postID=6869541598295304952' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default/6869541598295304952'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default/6869541598295304952'/><link rel='alternate' type='text/html' href='http://mednest.blogspot.com/2011/01/new-zealand-global-ambition-convergence.html' title='New Zealand: a Global Ambition: Convergence of Medical Technologies and Health IT'/><author><name>MedNest</name><uri>http://www.blogger.com/profile/14190789665083370179</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='29' src='http://4.bp.blogspot.com/_vjdz7sQNGZs/TUVnN-atcYI/AAAAAAAAAyw/ZBkAnA6JEcg/s220/MedNEst%2BBlue%2BCross.JPG'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7067887818437344832.post-947164150320590790</id><published>2011-01-30T05:29:00.000-08:00</published><updated>2011-01-30T06:48:53.035-08:00</updated><title type='text'>Austria - Going to America</title><content type='html'>&lt;strong&gt;Program Highlights:&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;Edited in collaboration with Advantage Austria, A series of three events in Linz, Innsbruck and Vienna, combining conferences and workshops on key topics related to the US MedTech and Healthcare industry:&lt;br /&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;Major Medical Needs and related demographics in the USA&lt;/li&gt;&lt;li&gt;Recent evolutions in the regulatory framework related to convergent technologies&lt;/li&gt;&lt;li&gt;Fundamentals of the US Healthcare Economic system&lt;/li&gt;&lt;li&gt;Presentation of specific opportunities for Entrepreneurs&lt;/li&gt;&lt;li&gt;Presentation of specific technology partnership needs of major US corporations&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Program Presenter: Mednest's Mathieu Petitjean, Ph.D.&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7067887818437344832-947164150320590790?l=mednest.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mednest.blogspot.com/feeds/947164150320590790/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=7067887818437344832&amp;postID=947164150320590790' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default/947164150320590790'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default/947164150320590790'/><link rel='alternate' type='text/html' href='http://mednest.blogspot.com/2011/01/austria-going-to-america.html' title='Austria - Going to America'/><author><name>MedNest</name><uri>http://www.blogger.com/profile/14190789665083370179</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='29' src='http://4.bp.blogspot.com/_vjdz7sQNGZs/TUVnN-atcYI/AAAAAAAAAyw/ZBkAnA6JEcg/s220/MedNEst%2BBlue%2BCross.JPG'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7067887818437344832.post-2615524485267028534</id><published>2008-07-06T11:41:00.000-07:00</published><updated>2008-07-06T11:44:17.229-07:00</updated><title type='text'>Welcome</title><content type='html'>Welcome to the MedNest Blog.&lt;br /&gt;&lt;br /&gt;MedNest (&lt;a href="http://www.mednest.com/"&gt;www.mednest.com&lt;/a&gt;)  sources and develops the business of innovative Medical Technology companies for the US Markets.&lt;br /&gt;&lt;br /&gt;We offer Busines Operations and Clinical Operations shared Services for entrepreuneurs, mid-stage companies and Venture Capital firms to bridge innovative products to he US healthcare Markets&lt;br /&gt;&lt;br /&gt;Welcome !&lt;br /&gt;&lt;br /&gt;Mathieu&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7067887818437344832-2615524485267028534?l=mednest.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mednest.blogspot.com/feeds/2615524485267028534/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=7067887818437344832&amp;postID=2615524485267028534' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default/2615524485267028534'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7067887818437344832/posts/default/2615524485267028534'/><link rel='alternate' type='text/html' href='http://mednest.blogspot.com/2008/07/welcome.html' title='Welcome'/><author><name>MedNest</name><uri>http://www.blogger.com/profile/14190789665083370179</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='29' src='http://4.bp.blogspot.com/_vjdz7sQNGZs/TUVnN-atcYI/AAAAAAAAAyw/ZBkAnA6JEcg/s220/MedNEst%2BBlue%2BCross.JPG'/></author><thr:total>0</thr:total></entry></feed>
